LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)

Clinical trials for LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) trials appear

Sign up with your email to follow new studies for LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

AI helps target stomach cancer with less harm to healthy organs

Disease control Not yet recruiting

This study tests a new way to deliver radiation for gastric MALT lymphoma. Using AI, the treatment adapts each session to better protect nearby organs. About 25 adults with early-stage disease will take part. The goal is to see if this approach is safe and effective.

Matched conditions: LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)

Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 17, 2026 04:25 UTC

LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)

Get alerted when new LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) trials appear

AI helps target stomach cancer with less harm to healthy organs